Dahuang-Wumei decoction protects against hepatic encephalopathy in mice: Behavioural, biochemical, and molecular evidence
- 5 February 2024
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 128, 155419
Abstract
No abstract availableKeywords
Funding Information
- Zhongnan Hospital of Wuhan University (ZNYB2022021)
- National Natural Science Foundation of China (81903965)
- Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
- China Postdoctoral Science Foundation (2022M722483)
This publication has 36 references indexed in Scilit:
- Management of Hepatic Encephalopathy Associated with Advanced Liver DiseaseClinical Drug Investigation, 2022
- Amino acids, ammonia, and hepatic encephalopathyAnalytical Biochemistry, 2022
- Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive DisorderCellular and Molecular Neurobiology, 2021
- Emodin Attenuates Acetaminophen-Induced Hepatotoxicity via the cGAS-STING PathwayInflammation, 2021
- Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disordersArchives of Pharmacal Research, 2021
- Blood-Brain Barrier (BBB) Permeability and Transport Measurement In Vitro and In Vivo2020
- The blood-brain barrier in systemic inflammationBrain, Behavior, and Immunity, 2017
- Crosstalk between Agrin and Wnt signaling pathways in development of vertebrate neuromuscular junctionDevelopmental Neurobiology, 2014
- In Vitro Models of the Blood–Brain Barrier2014
- Temozolomide down-regulates P-glycoprotein in human blood–brain barrier cells by disrupting Wnt3 signalingCellular and Molecular Life Sciences, 2013